BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Aerie Pharmaceuticals, Inc. (AERI) Elects Benjamin F. Mcgraw, III To Its Board Of Directors 10/7/2014 10:55:05 AM
Aerie Pharmaceuticals, Inc. (AERI) Announces Closing Of $125 Million Convertible Notes Financing 10/1/2014 9:34:49 AM
New Jersey's Aerie Pharmaceuticals, Inc. (AERI) Grabs $125 Million Financing Commitment 9/9/2014 6:08:03 AM
Aerie Pharmaceuticals, Inc. (AERI) Initiates Phase 3 Safety-Only Registration Trial in Canada Of Rhopressa™ In Patients With Glaucoma 9/3/2014 12:34:31 PM
Aerie Pharmaceuticals, Inc. (AERI) To Present At The Canaccord Genuity 34th Annual Growth Conference 8/7/2014 10:56:46 AM
Aerie Pharmaceuticals, Inc. (AERI) Receives Health Canada "No Objection Letter" To Commence Phase 3 Registration Trial Of Rhopressatm In Patients With Glaucoma In Canada 7/24/2014 1:02:16 PM
Aerie Pharmaceuticals, Inc. (AERI) To Announce Second Quarter 2014 Financial Results And Host Conference Call On Wednesday, August 6, 2014 7/23/2014 1:08:59 PM
Aerie Pharmaceuticals, Inc. (AERI) Initiates Phase 3 Registration Trials of Rhopressa™, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma 7/15/2014 11:21:49 AM
Aerie Pharmaceuticals, Inc. (AERI) Expands Management Team, Names Michael McCleerey As Vice President, Marketing 7/8/2014 10:53:55 AM
Aerie Pharmaceuticals, Inc. (AERI) Soars As Combo Eye Drug Roclatan Performs Well In Phase 2b Trial; Stock Up +28.29% At Market Close (June 25, 2014) 6/25/2014 6:39:50 AM
12345